315 results on '"Oldham, R K"'
Search Results
2. Treatment Of Oat Cell Carcinoma Of The Lung: Complete Remissions, Acceptable Complications, And Improved Survival
3. Application of Monoclonal Antibodies in Imaging and Therapy
4. High-Dose Methotrexate in Combination Chemotherapy for Small Cell Lung Cancer
5. A Study of Viral Infections in Patients Treated with a Combination of 6 Mercaptopurine-Methotrexate: Preliminary Results
6. Malignancies Possibly Secondary to Anticancer Therapy
7. Immune Responsiveness in Acute Lymphocytic Leukemia Patients under Chemotherapy and Immunotherapy: A Preliminary Report
8. Small-cell lung cancer: A curable disease
9. Immunologic monitoring and immunotherapy in Ewing's sarcoma
10. Malignancies Possibly Secondary to Anticancer Therapy
11. Immune Responsiveness in Acute Lymphocytic Leukemia Patients under Chemotherapy and Immunotherapy: A Preliminary Report
12. Introduction
13. A Study of Viral Infections in Patients Treated with a Combination of 6 Mercaptopurine-Methotrexate: Preliminary Results
14. High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer
15. Introduction
16. SURVIVAL OF PATIENTS WITH METASTATIC CANCER FOR MORE THAN THREE YEARS AFTER STARTING CONTINUOUS INFUSION IL-2 THERAPY IN TRIALS OF THE NATIONAL BIOTHERAPY STUDY GROUP (NBSG)
17. CHEMO-BIOTHERAPY WITH 5-FLUOROURACIL, LEUCOVORIN, MITOMYCIN-C AND ALPHA-INTERFERON IN METASTATIC ADENOCARCINOMA OF THE PANCREAS
18. CHEMO-BIOTHERAPY WITH 5-FLUOROURACIL, LEUCOVORIN AND ALPHA INTERFERON IN PATIENTS WITH METASTATIC ADENOCARCINOMA OF THE COLON. A PHASE II PILOT STUDY
19. High-dose continuous infusion interleukin-2 in the treatment of metastatic melanoma
20. CANCER BIOTHERAPY
21. HIGH DOSE CONTINUOUS INFUSION INTERLEUKIN-2 IN 788 CANCER PATIENTS
22. Continuous interleukin-2 and lymphokine-activated killer cells for advanced cancer: a National Biotherapy Study Group trial.
23. Recombinant Interleukin-2 and Adoptive Immunotherapy Alternated With Dacarbazine Therapy in Melanoma: A National Biotherapy Study Group Trial
24. Contrast medium "recalls" interleukin-2 toxicity.
25. PVB Chemotherapy: Cost-Benefit Analysis
26. Endodermal sinus tumor of the mediastinum.
27. Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies. II. Chromosomal and immunologic abnormalities.
28. Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies: clinical description.
29. Acute myelomonocytic leukemia associated with paraproteinemia.
30. Immunological monitoring and immunotherapy in carcinoma of the lung.
31. Cryopreservation of human lymphocyte function as measured by in vitro assays.
32. Inpatient continuous-infusion interleukin-2 in 788 patients with cancer. The National Biotherapy Study Group experience.
33. Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial.
34. Tumor acquisition, propagation, and preservation. The culture of human colorectal cancer.
35. Adjuvant chemoimmunotherapy stage i/ii malignant melanoma.
36. The Rationale for and Design of a Screening Procedure for the Assessment of Biological Response Modifiers for Cancer Treatment.
37. The relative proliferation index as a more sensitive parameter for evaluating lymphoproliferative responses of cancer patients to mitogens and alloantigens.
38. Eosinophilic granuloma.
39. Unusual survival after pulmonary artery sarcoma.
40. Vincristine-induced syndrome of inappropriate secretion of antidiuretic hormone.
41. Leukocyte Migration Inhibition by Soluble Extracts of MCF-7 Tissue Culture Cell Line Derived From Breast Carcinoma2
42. Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon.
43. Direct Comparison of Three Isotopic Release Microtoxicity Assays as Measures of Cell-Mediated Immunity to Gross Virus-Induced Lymphomas in Rats
44. MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody.
45. Cytotoxicity Inhibition Assay: Cryopreservation and Standardization: Brief Communication
46. A Multiple-Dose Phase I Trial of Recombinant Leukocyte A Interferon in Cancer Patients
47. Determination of the optimal human cell lines for development of human hybridomas.
48. Guinea pig line 10 hepatocarcinoma model for monoclonal antibody serotherapy: in vivo localization of a monoclonal antibody in normal and malignant tissues.
49. Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration.
50. Production of large quantities of human immunoglobulin in the ascites of athymic mice: implications for the development of anti-human idiotype monoclonal antibodies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.